Cellectar Biosciences (CLRB) Announces Patents for PDC Optical Agents in Detection of Multiple Cancers
Tweet Send to a Friend
Cellectar Biosciences, Inc. (Nasdaq: CLRB) today announces the United States Patent and Trademark Office has granted a method of use ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
